AtomVie Global Radiopharma
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $90M
Investors
- 1
About AtomVie Global Radiopharma
Founded in 2021 and based in Ontario, Canada, AtomVie Global Radiopharma Inc. is a spinout from the CPDC (Centre for Probe Development and Commercialization) and operates as a manufacturer and distributor of radiopharmaceuticals. As of 2023, Bruno Paquin is the CEO of the company. The company provides process and method development and validation; technical, regulatory, quality, logistics; clinical and commercial manufacturing; and specialized infrastructure for radiotherapeutic development from phase 1 to the commercial marketplace. The firm specializes in radiopharmaceutical manufacturing, including radiolabeling using radioisotopes such as Lu-177, Ac-225, and I-131, as well as ligands ranging from tiny compounds to peptides to small and big antibodies.
Who invested in AtomVie Global Radiopharma
1 investor across 1 round
See all investors in AtomVie Global Radiopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 1, 2023
Amount
$90M
Investors
Questions about AtomVie Global Radiopharma
Who invested in AtomVie Global Radiopharma?
AtomVie Global Radiopharma has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AtomVie Global Radiopharma raised?
AtomVie Global Radiopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did AtomVie Global Radiopharma last raise money?
AtomVie Global Radiopharma's most recent round on record is a Series A, in Jun 2023.
What does AtomVie Global Radiopharma do?
Founded in 2021 and based in Ontario, Canada, AtomVie Global Radiopharma Inc.
Where is AtomVie Global Radiopharma headquartered?
AtomVie Global Radiopharma is headquartered in Canada.
Which VCs invest in companies like AtomVie Global Radiopharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at AtomVie Global Radiopharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like AtomVie Global Radiopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.